Drug intelligence / Profile preview

prilocaine

Development stage
Approved
Modality
Small Molecules
Administration
Topical, Intravenous, Infiltration, Nerve Block
01

Overview

Prilocaine is a local anesthetic of the amino amide type, primarily used for local anesthesia in dental procedures and minor surgeries. It was first prepared by Claes Tegner and Nils Löfgren. Prilocaine acts by stabilizing the neuronal membrane through inhibition of sodium ion influx via voltage-gated sodium channels on nerve cells, thereby preventing initiation and conduction of nerve impulses. This action results in reversible loss of sensation in the targeted area. Prilocaine is often chosen for its relatively low cardiac toxicity compared to other local anesthetics and is commonly used for intravenous regional anesthesia (IVRA). In topical preparations, it may be combined with lidocaine (as EMLA) for dermal anesthesia[1][5][7][8].

Brand names
CitanestEMLA
Other names
prilocaine hydrochlorideEMLA (when in combination with lidocaine)
02

Targets

SCN9A (Sodium channel protein type 9 subunit alpha)SCN5A (Sodium channel protein type 5 subunit alpha)

Beyond the preview

Go deeper on prilocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prilocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call